Hidroderm

Quick links to important sections

Hidroderm

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hidroderm

Property Description
Active Ingredient Urea (Carbamide)
Form Topical Preparation (e.g., Cream, Lotion, Foam)
Pharmacological Class Keratolytic Agent and Emollient
Common Use Relief for dry, rough, or thickened skin
Origin Synthetic

Hidroderm is a medicinal product designed for topical application on the skin, categorized as a specialized keratolytic agent and an emollient. Its identity is defined by its single active component, Urea, which is chemically known as Carbamide. This formulation provides a specialized approach for managing conditions marked by skin dryness, roughness, or abnormal thickening.


Defining Hidroderm: Type and Classification

Hidroderm is a pharmaceutical entity recognized for its dual function: it is both a keratolytic (a skin-shedding agent) and a highly effective humectant (a moisturizer). This classification is derived from the established pharmacological actions of its active ingredient, Urea. When applied topically, urea is effective in breaking down and shedding the outer layers of skin. This means the medicine helps to safely remove excess scales and hard patches. For pharmaceutical applications, the Urea found in Hidroderm is synthetically produced to ensure purity and consistency, and it is intended exclusively for the topical route of administration onto the skin surface, making it suitable for targeted application to specific affected areas.


General Purpose and Mechanism Principle

The general purpose of Hidroderm is to relieve discomfort and normalize the texture of skin suffering from excessive dryness, roughness, or scaling. This is achieved because Urea operates on two mechanism principles: it draws water into the outer skin layer (hydration) and gently breaks down the tough protein keratin (keratolysis). Topical urea is recognized for its ability to increase the water content of the skin's outer layer. The medicine has a capacity to restore moisture to dry skin, a typical use scenario being the softening of callused skin on the feet. By combining these actions, the product helps restore moisture balance and promotes the smooth, natural shedding of dead cells, thereby supporting the overall integrity and function of the skin barrier.

What side effects are possible with Hidroderm?

Possible Side Effects and Safety Information

The safety profile of topical Urea (Hidroderm) is primarily characterized by localized cutaneous reactions that occur at the application site. Adverse effects are classified by regulatory authorities based on the system or organ affected.


Documented Adverse Reactions

The most frequently documented effects fall under Skin and Subcutaneous Tissue Disorders. These are often described in regulatory labels as being transient, meaning they are temporary and may disappear upon discontinuing the medication. Reactions typically include stinging, burning sensation, local irritation, pruritus (itching), and erythema (redness). The frequency of many of these events is generally reported as Not Known across regulatory texts, as definitive incidence rates are not available from spontaneous reporting.

Serious Safety Considerations and Constraints

The most critical safety constraint listed in official documentation is hypersensitivity to the active substance or any excipients, which represents an absolute contraindication for use.

Safety Domain Regulatory Constraint
Special Populations Use on large skin areas is restricted in individuals with renal insufficiency, as stated in SmPC-aligned regulatory texts.
Application Site The product must not be applied to acutely inflamed or excoriated (broken) skin and must avoid contact with mucous membranes and eyes.
Drug Interactions (Safety Consequence) Urea is documented to increase the penetration and potential systemic absorption of other co-applied topical medicines (e.g., corticosteroids, fluorouracil), a factor noted as a safety consideration.

These safety classifications reflect how government regulatory documents organize and communicate the medicine’s established risk profile.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory information for topical urea preparations like Hidroderm focuses on the critical risk of accidental ingestion rather than systemic overdose from excessive skin application. Systemic toxicity is generally not expected from topical overuse, as documented in regulatory prescribing information.


Documented Manifestations and Actions

The most common consequence of applying too much product is local irritation, which may include transient symptoms such as redness (erythema), a burning sensation, or itching (pruritus). These effects typically resolve upon discontinuing use.

Situation Required Emergency Action
Accidental Ingestion Seek immediate medical attention or contact a Poison Control Center right away.
Severe Symptoms For life-threatening symptoms, such as trouble breathing or passing out, call emergency services immediately.

Population-Specific Overdose Considerations

The product is strictly for external use and must be kept out of the reach of children. Special caution is warranted for infants and individuals with impaired kidney function (renal insufficiency), as there is a heightened official concern for increased systemic absorption in these populations. Individuals with renal impairment are advised against using the product on large skin areas.

Therapeutic Uses of Hidroderm

What Hidroderm Treats: Main Uses and Benefits

Hidroderm is a specialized topical preparation whose main therapeutic goal plays a role in managing symptoms related to skin texture abnormalities and moisture deficiency. Its use may assist with managing chronic dermatological discomfort and contributes to general well-being during symptomatic phases.

The application of this topical treatment is relevant for managing hyperkeratotic and dry skin conditions. Its use is focused on easing symptoms related to severe xerosis, ichthyosis, psoriasis, calluses, and corns.


Key Symptom Management

The treatment is commonly used to help with symptom clusters that may become intense or disruptive, such as those related to hyperkeratosis. It is also relevant for easing symptoms related to pathological dryness (xerosis) and associated symptom clusters like roughness, scaling, flaking, and skin tightness.

This preparation is often used in a long-term, supportive capacity to manage the characteristic dryness and scaling of chronic conditions, including atopic dermatitis (eczema) and recurring psoriasis.

“Consistent application supports the management of recurrent or episodic manifestations, which helps patients cope more steadily with symptom fluctuations.”

This supportive benefit may assist with managing symptoms that create noticeable physiological strain, providing ongoing maintenance support that contributes to easing the overall symptom load during periods of heightened symptoms.

Quick Fact: Relief for Hardened Skin, Severe Dryness, and Scaling.

Regulatory References

  1. DailyMed (National Library of Medicine) overview

Eligibility and Restrictions for Use

Who can and cannot use Hidroderm?

Official regulatory documents strictly define the population eligibility for Hidroderm (Urea Topical) based on mandatory contraindications, physiological status, and age-related data.


Populations Excluded or Restricted from Use

  • Contraindicated Populations: Use is absolutely prohibited for patients with a known hypersensitivity (allergic reaction) to Urea (Carbamide) or any other ingredient in the formulation.
  • Application Site Restrictions: The medicine must not be applied to areas of irritated, broken, infected skin, or open wounds. Contact with eyes, lips, or mucous membranes must be strictly avoided.

Conditional Eligibility and Status Constraints

  • Pregnancy and Lactation: For pregnant women, the medicine should be used only if clearly needed and when potential benefits outweigh hazards. Caution must be exercised when administered to nursing mothers, as it is not established whether the drug is excreted in human milk.
  • Pediatric Use: Use in pediatric populations is not established by regulatory safety and efficacy data, and caution is advised for this age group.

Adults and older adults are eligible for standard use, and official labeling notes no specific restrictions for patients with hepatic or renal impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory interaction profile for topical urea, the active ingredient in Hidroderm, is primarily defined by the absence of systemic interactions. Official documentation, including government drug labels, does not contain information detailing systemic pharmacokinetic interactions, such as those involving CYP enzymes or drug transporters, due to the medicine’s minimal absorption into the bloodstream after topical application.

Local Pharmacodynamic Interactions

While systemic interactions are not documented, official regulatory information focuses on potential local pharmacodynamic interference at the site of application. Two primary interaction cautions are documented:

  • Other Topical Preparations: Co-administration of other topical skin products on the same application area may lead to additive skin effects or local irritation. Official labeling cautions against the concurrent use of different products without professional guidance.
  • Enzymatic Debriding Agents: Topical urea is noted to potentially interfere with the enzymatic activity of certain topical enzymatic debriding agents, such as collagenase. This interference may reduce the intended effectiveness of the co-administered enzymatic agent.

Contraindications and Timing Rules

No systemic drug combinations are formally classified as contraindicated due to interaction with topical urea. Furthermore, regulatory labels do not specify any mandatory timing-based separation rules for co-administering other medicinal products.

Mechanism of Action

Dual Pharmacodynamics of Urea in the Stratum Corneum

The action of Hidroderm is driven by the intrinsic properties of its single active component, Urea, which exerts a dual physicochemical effect exclusively within the stratum corneum.

Targeting Epidermal Water Regulation (Humectant Action)

Urea functions as a humectant, engaging water molecules ( H2 O) through hydrogen bonding and modulating Aquaporin-3 channels. This molecular action increases the water content within the corneocytes and the epidermal barrier. The consequence is the physiological effect of enhanced plasticity and increased water retention capacity of the outermost skin layer.

Disrupting Corneocyte Cohesion (Keratolytic Action)

This domain involves Urea acting as a mild denaturing agent. It selectively disrupts the non-covalent structural bonds within the Keratin proteins and the corneodesmosomes that link adjacent dead skin cells. This molecular weakening of cell cohesion facilitates desquamation (shedding), producing the physiological effect of reducing aggregated corneal layers and modulating epidermal thickness.

Dosage and Administration Information

How to Use Hidroderm: Administration and Usage

Hidroderm (topical urea) is a pharmaceutical preparation whose usage is characterized by its specified route, frequency, and application technique.


General Administration Scope

Feature Instruction
Route of administration TOPICAL and EXTERNAL USE ONLY.
Dosing schedule Apply a quantity sufficient to cover the affected skin area(s) or diseased nail(s).
Frequency pattern Twice per day (b.i.d.) or up to two to three times per day as directed by a physician.
Age-group rules No specific dose adjustments are outlined for older adults or pediatric patients.

Procedural and Contextual Instructions

The usage protocol is standardized to provide for proper administration. The preparation, which is typically a high-strength cream (e.g., 40% urea), requires no dilution or specific preparation prior to application. Following the prescribed frequency, the product should be applied to the target area and rubbed in until completely absorbed into the skin or nail surface.

It is an essential procedural constraint that the application must avoid contact with eyes, lips, and mucous membranes and is NOT FOR OPHTHALMIC USE. Use is continued as directed by a physician for the duration of the hyperkeratotic condition, without a set maximum duration defined. This structured approach ensures the medication is used precisely for its localized external application.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Hidroderm

Evidence for Use in Atopic Dermatitis (Eczema)

Research exploring Hidroderm was studied for Atopic Dermatitis (Eczema) and has focused primarily on short-term, randomized, controlled trials (RCTs). These studies were designed to evaluate the product under controlled conditions, often comparing it to an inactive product (a vehicle or placebo) over a defined period. Research examined outcomes related to physical discomfort and inflammatory or irritative states, primarily using standardized scoring systems like the Eczema Area and Severity Index (EASI) and the SCORAD Index. These scales are used to monitor variables like the size and intensity of the skin condition. The research populations included adult and adolescent subjects whose Atopic Dermatitis was classified as mild-to-moderate severity.

Studies report how symptoms evolved in the observed populations across the short-term study periods, which often lasted between 4 and 12 weeks. Research describes changes measured during the study period for skin barrier function, using metrics like Transepidermal Water Loss (TEWL), and how patients reported their experience of itching (pruritus). Data for these measurements were described in the studies, but findings across different studies were sometimes mixed. Studies contribute to the broader evidence landscape related to short time frames.

Evidence for Use in Chronic Hand Dermatitis

For Chronic Hand Dermatitis, the evidence landscape differs, consisting mainly of pilot studies and smaller Phase 2 trials. These research efforts explored symptom intensity and variability in adults diagnosed with moderate-to-severe Chronic Hand Dermatitis. Studies monitored outcomes using specific assessments like the Hand Eczema Severity Index (HECSI). These studies describe how symptoms are measured and report how patient-reported experiences evolved over defined time intervals.

Long-Term Studies and Uncertainty

Long-term outcomes are not fully established for either indication. The majority of published research was conducted as short-term or intermediate-term studies, with limited follow-up durations. The existing studies provide limited insight into whether the measured changes are sustained over extended periods. Data are still emerging to explore long-term outcomes and consistency across larger and more diverse populations. Furthermore, there is limited information for certain groups, such as children under the age of 12 or women who are pregnant or breastfeeding, as these subjects were often excluded from initial clinical trials.

Frequently Asked Questions (FAQ)

Common questions about Hidroderm (FAQ)


Q: Can Hidroderm be used during pregnancy or while breastfeeding?

Official information describes Hidroderm (high-strength urea) as falling into Pregnancy Category B or C, depending on the specific product label. Category B indicates that animal studies show no evidence of harm to the fetus, but adequate human studies have not been performed. For nursing mothers, it is not currently known whether the drug passes into human milk, and official information recommends caution.


Q: Is it normal to feel a slight stinging or burning when first applying Hidroderm?

Regulatory documents state that temporary local reactions are possible. Transient side effects, such as stinging, burning, itching, or general skin irritation, are sometimes reported. Official product information notes these sensations typically resolve after the product is discontinued.


Q: What are the serious but rare side effects of Hidroderm described in official documents?

The most noted serious risk described in regulatory documents is a known hypersensitivity, which is a severe allergic reaction to urea or any of the inactive ingredients. Official labeling indicates that the product should be discontinued if redness, irritation, or a rash occurs or worsens.


Q: Are there any common reasons why someone might be told they cannot use Hidroderm?

The primary reason listed in official documentation is a known or suspected hypersensitivity to the active component, urea, or any of the other components in the cream. This means that if a person has a confirmed severe allergy to the product, its use is generally prohibited (contraindicated).


Q: What kinds of infections or skin breaks are listed as preventing the use of Hidroderm?

Some versions of the product label explicitly caution against applying the cream to broken skin. While Hidroderm is used to help manage skin lesions where healing is slowed by debris or local infection, official directions advise using the product only as prescribed for a specific condition.


Q: What should a patient generally expect when starting treatment with Hidroderm?

A patient should expect that this is a topical (external use) medication intended to loosen and soften the thickened top layer of skin. It is noted in official information that some temporary local effects, such as minor stinging or burning, may occur when first starting treatment.


Q: Can children or the elderly use Hidroderm?

For older adults, official regulatory documents generally do not outline mandatory dose adjustments. For children, some regulatory labels state that the safety and efficacy of the high-concentration formulation have not been established in pediatric patients.


Q: What are the requirements for storing Hidroderm?

Official product information requires Hidroderm to be stored at Controlled Room Temperature, typically between 15 C and 30 C (59 F and 86 F). The product must also be protected from freezing.


Q: Is there a generic version of Hidroderm available, or is it only brand name?

Hidroderm is the brand name for one specific formulation of high-strength urea cream. The active ingredient, Urea, is widely available in generic creams and ointments in various concentrations from multiple different manufacturers.


Q: What are the restrictions on how long Hidroderm can be used continuously?

According to official administration guidelines, the use of Hidroderm is continued as directed by a healthcare professional for the duration of the hyperkeratotic condition. General prescribing information does not define a set maximum duration of continuous use.


Q: Does Hidroderm have any ingredients that are known allergens?

Official regulatory documents list both the active ingredient (urea) and all inactive ingredients (excipients) in the product. Warnings state that the product is contraindicated if a person has a known or suspected hypersensitivity to any of the listed ingredients.


Q: Is Hidroderm a prescription-only medicine?

High-concentration formulations of urea cream, such as the one marketed under the name Hidroderm, are typically classified as 'Rx Only' (prescription-only) in the United States.


Q: Can Hidroderm be used for skin issues other than the main described uses?

Official regulatory documents state that this medication is not intended for use to treat any condition other than that for which it was prescribed. The application must be limited to the approved uses described in the product labeling.


Q: Do you have to use Hidroderm forever, or is it a short-term treatment?

The treatment is intended to be used for the duration of the specific skin condition, or as determined by a healthcare professional. It is not generally described as a medication that must be used indefinitely or 'forever.'


Q: How does Hidroderm interact with moisturizers or other skin care products?

Official information includes a caution against the concurrent use of other topical skin products on the same application area. This is because combining products may lead to additive effects or increased local skin irritation.


Q: What happens if too much Hidroderm is applied?

While regulatory guidelines do not specify systemic overdose warnings for topical application, applying more than the prescribed amount may increase the potential for local adverse reactions. Official documents indicate that use may need to be discontinued if skin irritation or redness occurs.


Q: What happens if a person misses a time they were supposed to use Hidroderm?

General patient information for this type of medication advises using the missed amount as soon as it is remembered. However, if it is almost time for the next scheduled application, the missed amount should be skipped, and the regular schedule should be continued. Official patient information generally states that the amount used should not be doubled to compensate for a missed application.


Q: What does the research evidence say about long-term use of Hidroderm?

Regulatory documents note that long-term animal studies to evaluate the potential for causing cancer (carcinogenic potential) have not been performed for this product. The duration of use is generally determined by a healthcare professional based on the individual's specific condition.


Q: Is the sensation of 'tightness' sometimes described as a side effect?

While common local reactions like stinging, burning, itching, and irritation are explicitly listed in the official adverse reactions sections, the specific feeling of 'tightness' is not generally mentioned in regulatory documents.


Q: How long after stopping Hidroderm do the components stay in the body or system?

Official pharmacokinetic information notes that the systemic absorption of urea after topical application is minimal. Detailed pharmacokinetics, such as the exact time for full clearance from the system, is not typically defined in the regulatory labeling.


Q: Can Hidroderm affect the results of blood tests or other medical tests?

Official product information notes that systemic absorption is minimal after topical use. For this reason, official regulatory labels generally do not document systemic drug interactions, suggesting a very low likelihood of affecting blood test results.


Q: What does the packaging or label of Hidroderm typically show?

The official product label typically shows the active ingredient (Urea) and its specific concentration (e.g., 40%), the Net Weight of the product, the classification as 'Rx Only' (prescription only), and mandatory warnings like 'For External Use Only.'


Q: Why is a specific condition listed in the 'Who can and cannot use' section for Hidroderm?

A condition would be listed in the 'cannot use' section (known as a contraindication) if there is a known or suspected risk, such as a severe allergic reaction (hypersensitivity) to any component of the product, which would pose a direct health risk.


Q: Do people sometimes use Hidroderm for cosmetic purposes, and is this mentioned in official information?

Official regulatory information focuses only on the approved medical uses of the product. The documentation indicates that the medication is not intended for use to treat any condition other than those for which it was prescribed.

How should Hidroderm be stored and disposed of?

How to Store and Dispose of Hidroderm

Official regulatory information requires that Hidroderm be stored according to specific environmental and handling standards to ensure product stability and safety. The following instructions are based on government-mandated labeling for storage and disposal.

Storage Requirements

Condition Official Regulatory Requirement
Temperature Store at controlled room temperature, typically below 25 C (77 F).
Protection Keep the product in the original, tightly closed container and protect it from light and moisture.
Handling Do not freeze the product and avoid excessive heat.
Stability Keep out of the sight and reach of children. Use within the 'in-use' period specified on the label after first opening.

Disposal Instructions

Do not dispose of unused or expired Hidroderm in household trash, down the drain, or down the toilet. Follow official regulatory guidance by returning the unused medicine to a pharmaceutical take-back program or a designated collection location, as mandated to prevent environmental exposure.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Hidroderm found in:

A-Z Index: